Frequency and level of evidence used in recommendations by the National Comprehensive Cancer Network guidelines beyond approvals of the US Food and Drug Administration: retrospective observational study

AbstractObjectiveTo determine the differences between recommendations by the National Comprehensive Cancer Network (NCNN) guidelines and Food and Drug Administration approvals of anticancer drugs, and the evidence cited by the NCCN to justify recommendations where differences exist.DesignRetrospecti...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	BMJ (Online) 2018-03, Vol.360, p.k668-k668
Hauptverfasser:	Wagner, Jeffrey, Marquart, John, Ruby, Julia, Lammers, Austin, Mailankody, Sham, Kaestner, Victoria, Prasad, Vinay
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic drugs Antitumor agents Cancer therapies Clinical medicine Drugs FDA approval Marketing Observational studies Oncology Systematic review Womens health
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!